Author

Qiting Liu

Institutions: Chengdu Medical College, First Affiliated Hospital of Chengdu Medical College

Observed institutions: Chengdu Medical College, First Affiliated Hospital of Chengdu Medical College

ORCID: 0000-0001-6930-8685

Observed ORCID: 0000-0001-6930-8685

OpenAlex ID: A5065864950

Adrenal Ablation Versus Mineralocorticoid Receptor Antagonism for the Treatment of Primary Aldosteronism: A Single-Center Prospective Cohort Study

2022 · Yaqiong Zhou, Qiting Liu, et al. · American Journal of Hypertension · 28

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism

2023 · Yaqiong Zhou, Xinquan Wang, et al. · Hypertension Research · 20

Capsaicin Prevents Contrast‐Associated Acute Kidney Injury through Activation of Nrf2 in Mice

2022 · Fei Ran, Yi Yang, et al. · Oxidative Medicine and Cellular Longevity · 17

Case report: Percutaneous adrenal arterial embolization cures resistant hypertension

2022 · Yaqiong Zhou, Dan Wang, et al. · Frontiers in Cardiovascular Medicine · 12

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy

2023 · Yi Yang, Xinquan Wang, et al. · Hypertension Research · 3

Works count: 5

Citation count: 80

H-index: 4

I10-index: 4